Stockscreener 앱 받기
204.28
1.80%
3.61
시간 외 거래:
203.01
-1.27
-0.62%
Natera Inc 주식(NTRA)의 최신 뉴스
How to integrate Natera Inc. into portfolio analysis toolsAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Will Natera Inc. stock beat EPS estimates2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
How Natera Inc. stock reacts to bond yieldsJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Ranking Natera Inc. among high performing stocks via toolsProfit Target & Fast Moving Trade Plans - newser.com
How high can Natera Inc. stock go2025 Market Overview & Risk Managed Trade Strategies - newser.com
Does Natera (NTRA) Have a Long Runway For Growth? - Insider Monkey
Stephens Reaffirms Their Buy Rating on Natera (NTRA) - The Globe and Mail
Natera co-founder Sheena Jonathan sells $903k in stock By Investing.com - Investing.com South Africa
Automated trading signals detected on Natera Inc.Earnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Is Natera Inc. stock entering bullish territoryEarnings Overview Summary & AI Driven Price Predictions - newser.com
Published on: 2025-11-05 02:57:17 - newser.com
Natera price target raised to $235 from $17 at Stephens - TipRanks
NTRA: Stephens & Co. Raises Price Target on Natera to $235 | NTR - GuruFocus
Natera stock price target raised to $235 from $197 at Stephens - Investing.com
Natera Integrates with Flatiron Health’s OncoEMR® Platform - BioSpace
Can momentum traders help lift Natera Inc.2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Natera at UBS Global Healthcare Conference: Strategic Growth and Future Prospects - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $903k in stock - Investing.com India
Natera Integrates Oncology Testing into Flatiron’s OncoEMR® to Streamline Cancer Care - HIT Consultant
Natera at UBS Global Healthcare Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com South Africa
Natera, Inc. Integrates with Flatiron Health?S Oncoemr Platform - MarketScreener
Natera Integrates Oncology Tests With Flatiron's Electronic Medical Record Platform - MarketScreener
Natera (NTRA) Is Up 5.2% After Raising 2025 Revenue Guidance and Expanding Women’s Health Portfolio - simplywall.st
Natera announces data from PROCEED-CRC trial - MSN
Natera price target raised to $230 from $220 at Piper Sandler - TipRanks
NTRA: Piper Sandler Raises Price Target to $230, Maintains Overw - GuruFocus
Is Natera Inc. stock a defensive play in 2025Portfolio Risk Summary & Daily Stock Trend Watchlist - newser.com
Natera (NTRA): Valuation Insights Following Strong Q3 Results and Upbeat Guidance Boost - Yahoo Finance
Natera stock reaches all-time high at 203.78 USD By Investing.com - Investing.com Nigeria
Natera (NTRA) Q3 2025 Earnings Call Transcript - AOL.com
Will Natera Inc. stock outperform Nasdaq index2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Natera (NTRA): Reassessing Valuation After Raised 2025 Guidance and Strong Quarterly Results - simplywall.st
Natera price target raised to $250 from $200 at Canaccord - MSN
Natera raises 2025 revenue guidance to $2.18B–$2.26B amid record Signatera growth and increased gross margin - MSN
Is Natera Inc. stock positioned well for digital economy2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com
0.64%
0.03%
자본화:
|
볼륨(24시간):